Collaborate When Using Antiarrhythmics for Atrial Fib

February 2023

You’ll see antiarrhythmics used more often for “rhythm control” in some patients with atrial fib.

Older data found that reducing frequency and duration of atrial fib with antiarrhythmics doesn’t reduce mortality versus rate control with beta-blockers, CCBs, etc...and may increase hospitalizations.

Now data suggest that rhythm control may benefit patients with onset of atrial fib in the last year who are at high CV risk.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote